Effect of free versus liposomal-complexed pentamidine isethionate on biological characteristics of Acanthamoeba castellanii in vitro

Journal of Medical Microbiology

Volumn 58, Issue 3, 2009, Pages 327-330

  Siddiqui, Ruqaiyyah ^a,b   Syed, Abdul ^a   Tomas, Salvador ^a   Prieto Garcia, Jose ^c   Khan, Naveed Ahmed ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ERGOSTEROL; LIPOSOME; PENTAMIDINE ISETHIONATE; PHOSPHATIDYLCHOLINE;

ACANTHAMOEBA CASTELLANII; ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG POTENCY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

ACANTHAMOEBA CASTELLANII; ANIMALS; ANTIPROTOZOAL AGENTS; BRAIN; CELL ADHESION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; LIPOSOMES; PENTAMIDINE;

EID: 61449183510     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.006494-0     Document Type: Article

References (13)

1. Alizadeh, H., Silvany, R. E., Meyer, D. R., Dougherty, J. M. & McCulley, J. P. (1997). In vitro amoebicidal activity of propamidine and pentamidine isethionate against Acanthamoeba species and toxicity to corneal tissues. Cornea 16, 94-100.
2. Alsam, S., Kim, K. S., Stins, M., Rivas, A. O., Sissons, J. & Khan, N. A. (2003). Acanthamoeba interactions with human brain microvascular endothelial cells. Microb Pathog 35, 235-241.
3. Antimisiaris, S. G., Ioannou, P. V. & Loiseau, P. M. (2003). In vitro antileishmanial and trypanocidal activities of arsonoliposomes and preliminary in vivo distribution. J Pharm Pharmacol 55, 647-652.
4. Ficker, L., Seal, D., Warhurst, D. & Wright, P. (1990). Acanthamoeba keratitis - resistance to medical therapy. Eye 4, 835-838.
5. Khan, N. A. (2001). Pathogenicity, morphology, and differentiation of Acanthamoeba. Curr Microbiol 43, 391-395.
6. Khan, N. A. (2006). Acanthamoeba: biology and increasing importance in human health. FEMS Microbiol Rev 30, 564-595.
7. Marciano-Cabral, F. & Cabral, G. (2003). Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 16, 273-307.
8. Ning, M. Y., Guo, Y. Z., Pan, H. Z., Yu, H. M. & Gu, Z. W. (2005). Preparation and evaluation of proliposomes containing clotrimazole. Chem Pharm Bull (Tokyo) 53, 620-624.
9. Paul, M., Durand, R., Fessi, H., Rivollet, D., Houin, R., Astier, A. & Deniau, M. (1997). Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model. Antimicrob Agents Chemother 41, 1731-1734.
10. Sissons, J., Kim, K. S., Stins, M., Jayasekera, S., Alsam, S. & Khan, N. A. (2005). Acanthamoeba castellanii induces host cell death via a phosphatidylinositol 3-kinase-dependent mechanism. Infect Immun 73, 2704-2708.
11. Stins, M. F., Gilles, F. & Kim, K. S. (1997). Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 76, 81-90.
12. Turner, N. A., Russell, A. D., Furr, J. R. & Lloyd, D. (2000). Emergence of resistance to biocides during differentiation of Acanthamoeba castellanii. J Antimicrob Chemother 46, 27-34.
13. Visvesvara, G. S., Moura, H. & Schuster, F. L. (2007). Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol 50, 1-26.